Progress in percutaneous management of coronary bifurcation lesions

V Dzavik1

  • 1Interventional Cardiology Program, Division of Cardiology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada. vlad.dzavik@uhn.on.ca

Minerva Cardioangiologica
|September 24, 2005
PubMed

Insights

Percutaneous coronary intervention (PCI) for bifurcation lesions remains challenging, with various stenting techniques evolving to improve outcomes. Drug-eluting stents have enhanced long-term efficacy, but further randomized trials are needed to compare techniques for complex cases.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • Bifurcation lesions pose significant challenges in percutaneous coronary intervention (PCI).
  • Early PCI attempts focused on side branch protection, with stenting improving safety but not fully resolving challenges.
  • Long-term success was limited by target lesion revascularization and major adverse cardiac events.

Purpose of the Study:

  • To review the evolution of PCI techniques for bifurcation lesions.
  • To discuss the impact of drug-eluting stents and novel techniques on bifurcation PCI outcomes.
  • To highlight the need for comparative studies on bifurcation lesion management.

Main Methods:

  • Review of historical and current interventional cardiology practices for bifurcation lesions.
  • Discussion of various stenting techniques, including T-stenting, Culotte, and crush stenting.
  • Analysis of the role of drug-eluting stents and specialized bifurcation stents.

Main Results:

  • Stenting improved PCI safety and short-term outcomes for bifurcation lesions.
  • Drug-eluting stents have significantly enhanced long-term efficacy.
  • Specialty bifurcation stents have seen limited adoption; new techniques like crush stenting are emerging.

Conclusions:

  • A variety of PCI techniques exist for bifurcation lesions, each suited to specific anatomical scenarios.
  • Debate continues regarding the most efficacious technique.
  • Well-designed randomized trials are crucial for evaluating and comparing bifurcation PCI techniques, especially for complex lesions.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...